The stock showed down beat monthly and quarterly
performances and plunged -27.24% and -20.47%, respectively. Repros Therapeutics
Inc (NASDAQ:RPRX) has revealed an amended date for predictable clinical results
from the initial pivotal study, ZA-301, of Androxal(R) in the cure of secondary
hypogonadism.
Herbalife Ltd. (NYSE:HLF) was among the percentage losers
and was down -8.19%. HLF traded with volume of 28.15 million shares in the last
session. Tracking the prior trends of
HLF, it was a loser in its quarterly performance and dropped -22.41%. The
yearly performance of the stock was negative -28.74%. The YTD trend was in the
green as the stock escalated +21.49%.
Herbalife Ltd.
(NYSE:HLF) has scheduled to report its Q4 of 2012
financial results after the close of trading on the New York Stock Exchange on
February 19, 2013. The Company’s management has scheduled to host a conference
call on February 20, 2013 at 8 a.m. PST/ 11 a.m. Eastern Standard Time. For
accessing the conference call, the interested parties can utilize the dial in
numbers, (877) 317-1296 and (706) 634-5671 for international callers, by using
conference ID 90082326.
Another stock in the row of losers of the Healthcare Sector
was Star Scientific, Inc. (NASDAQ:STSI), as it decreased -5.42% and closed the
session at $2.27. STSI traded with volume of 2.89 million shares. The 52 week
range of the stock remained $1.56 - $5.05. STSI’s one month’s performance was
negative and the stock dropped -14.34%.The stock dropped -25.57% in its three
months performance.
Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) dropped -4.63%
in Monday’s session, to close at $4.74. The 52 week range of the stock remained
$1.27- $9.28. THLD traded with volume of 2.81 million shares, which was higher
than the average trading volume of 889,534 shares.
0 comments :
Post a Comment